Which hedge funds own NMRA? NEUMORA THERAPEUTICS INC., Q2 2026 13F holders
Healthcare · Open on the interactive board
5 of the hedge funds tracked by WhaleCreep disclosed a position in NMRA (NEUMORA THERAPEUTICS INC.) in their Q2 2026 13F filings, worth $8.3m in total. The largest holder by portfolio weight is Tudor Investment at 0.0% of its book. 3 exited: Brevan Howard Capital Management, Point72 Asset Management LP, Woodline Partners.
5tracked managers holding
0opened this quarter
3exited this quarter
Which hedge funds hold NMRA? Current holders by portfolio weight
| Manager | As of | Weight of book | Value | Shares | Δ shares | Action |
|---|---|---|---|---|---|---|
| Tudor Investment | Q2 2026 | 0.0% | $2.3m | 1,356,147 | 76% | added |
| Renaissance Technologies LLC | Q2 2026 | 0.0% | $2.1m | 1,262,304 | -9% | reduced |
| Marshall Wace | Q2 2026 | 0.0% | $1.5m | 904,458 | -24% | reduced |
| Citadel Advisors | Q2 2026 | 0.0% | $1.4m | 828,933 | 141% | added |
| Millennium Management | Q2 2026 | 0.0% | $865.7k | 509,210 | -82% | reduced |
Exited since the previous quarter
| Manager | Prior weight | Prior value |
|---|---|---|
| Brevan Howard Capital Management | 0.0% | $189.3k |
| Point72 Asset Management LP | 0.0% | $1.2m |
| Woodline Partners | 0.0% | $29.2k |
How has hedge fund ownership of NMRA changed?
| Quarter | Managers holding | Combined value |
|---|---|---|
| Q2 2026 | 5 | $8.3m |
| Q1 2026 | 8 | $14.0m |
| Q4 2025 | 3 | $9.2m |
| Q3 2025 | 2 | $2.1m |
| Q2 2025 | 2 | $1.1m |
| Q1 2025 | 2 | $1.3m |
| Q4 2024 | 1 | $3.3m |
| Q3 2024 | 3 | $28.9m |
| Q2 2024 | 2 | $19.3m |
| Q1 2024 | 2 | $26.7m |
| Q4 2023 | 2 | $34.2m |
| Q3 2023 | 2 | $25.5m |
Counts every tracked manager that disclosed NMRA in that quarter's filing, including managers that have since stopped filing.